Top 10 Sarcoma Journals

Article Contents

1. Introduction
2. An overview of important Journal Metrics
3. A list of the top ranked journals for this therapeutic area
4. Ways to stay up to date with the latest research developments

Introduction

July is Sarcoma Awareness Month, providing people with the opportunity to learn more about this rare form of cancer that claims the lives of more than 5,000 Americans annually. There’s still a lot that is unknown about sarcomas, which are cancerous tumors that can occur almost anywhere in the body. Primarily, they tend to develop in the bones and soft tissues – including fat, muscles, blood vessels, nerves, deep skin tissues, and fibrous tissues.

Here you will find the top 10 Sarcoma journals ranked by the 2-year Journal Impact Factor (2-JIF) – a measure of the frequency with which the articles within the journal are cited in a particular 2-year period.

We have also included some other factors for each journal in our assessment to round off the picture.

Journal Metrics

Impact factor

The Journal Impact Factor (JIF) is based on Web of Science data and only includes documents such as articles and reviews. The JIF helps to understand the importance of how often articles are cited by addressing the bias that arises from comparing citation numbers. This bias tends to advantage bigger journals over smaller ones, those published more often over those with fewer issues, and older journals over newer ones. This is because larger or older journals usually have more articles to be cited. By considering the impact factor, we can more fairly compare journals by taking into account these differences in size, publication frequency, and age. A JIF of 3 or more is considered good and 1 is average.

CiteScore

CiteScore is based on Scopus data for all indexed documents, including articles, letters and editorials, as well as articles and reviews. The CiteScore for a particular year is calculated by dividing the number of citations to all indexed documents within the journal from that year and the three preceding years by the total number of documents published in the journal within that same period.

• Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area. Many academics value a journal’s Impact Factor over its CiteScore; therefore, they will use the impact factor to rank other journals in the same field.

SCImago Journal Rank (SJR)

The SCImago Journal Rank (SJR) indicator evaluates the prestige of academic journals by considering not only the number of citations a journal receives but also the prestige of the journals that issue these citations. An SJR >1.0 is above average. This measurement can be helpful to rank journals within the same field and category.

Source Normalised Impact per Paper (SNIP)

Source Normalised Impact per Paper (SNIP) weights citations based on the total number of citations in a subject field to provide a contextual, subject-specific metric. A SNIP over 1.0 means a journal has more citations than average.

Other Journal considerations

In addition to SJR ranking and journal impact factor, a good quality journal generally has the following characteristics:

1. It is indexed on PubMed, Google Scholar, Scopus, Web of Science or another reputable journal index.
2. It has an up-to-date website, a clear scope, extensive information for authors and readers, and a publicly visible editorial board consisting of appropriately qualified board members affiliated with accredited universities and research institutions.
3. Each article is assigned a Digital Object Identifier (DOI).

Top 10 Sarcoma Journals

Selecting the right journal for your research is a critical step that can make or break the impact of your work. This is where a medcomms agency like Rx Communications can become an essential ally. With a deep understanding of the scientific publishing world and high levels of therapeutic area expertise, a medcomms agency worth its salt should be able to provide support at any stage of the publishing process. This includes assisting in finding journals that match your research area and larger aims, and shaping your manuscript so it reflects the ethos and audience of your chosen journal, as well as guiding you through the entire submission process including managing revisions, and planning for post-publication promotion and dealing with rejection.

Rx can increase your chances of not just getting published, but also ensuring your research makes the waves it deserves.

Ca: A Cancer Journal for Clinicians

The CA: A Cancer Journal for Clinicians is one of the world’s leading cancer journals, published by the American Cancer Society. It provides medical professionals with the latest information on cancer diagnosis, treatment, and prevention.

• Impact Factor: 254.7
• CiteScore: 642.9
• SJR: 86.091
• SNIP: 153.478
• H-Index: 198

Nature Reviews Clinical Oncology

Nature Reviews Clinical Oncology covers a wide range of oncology subjects, from diagnosis to experimental therapies, and is geared towards practicing doctors and researchers.

• Impact Factor: 78.8
• CiteScore: 75.5
• SJR: 14.809
• SNIP: 8.319
• H-Index: 198

Nature Reviews Cancer

Nature Reviews Cancer, published by the Nature Publishing Group, features reviews and commentary that are accessible and enhanced for optimal usability.

• Impact Factor: 78.5
• CiteScore: 96.7
• SJR: 20.977
• SNIP: 10.357
• H-Index: 484

The Lancet Oncology

The Lancet Oncology provides high-quality, peer-reviewed research and reports from clinical trials, challenging the status quo and advocating for changes in health policy.

• Impact Factor: 51.1
• CiteScore: 62
• SJR: 12.27
• SNIP: 10.918
• H-Index: 382

Annals of Oncology

Annals of Oncology is the journal of the European Society for Medical Oncology, focusing on systemic anticancer therapy and personalized medicine.

• Impact Factor: 50.5
• CiteScore: 63
• SJR: 11.945
• SNIP: 8.208
• H-Index: 277

Cancer Cell

Cancer Cell, published by Cell Press, promotes major advances in cancer research, focusing on translational research and clinical investigations.

• Impact Factor: 50.3
• CiteScore: 52.9
• SJR: 12.578
• SNIP: 5.274
• H-Index: 378

Journal of Hematology and Oncology

The Journal of Hematology & Oncology is an open-access journal that publishes articles on the latest developments in hematology and oncology.

• Impact Factor: 28.5
• CiteScore: 38.4
• SJR: 6.046
• SNIP: 4.045
• H-Index: 122

JAMA Oncology

JAMA Oncology, part of the JAMA Network, provides peer-reviewed articles on significant advances in oncology science.

• Impact Factor: 28.4
• CiteScore: 44.3
• SJR: 8.103
• SNIP: 6.653
• H-Index: 154

Clinical Cancer Research

Clinical Cancer Research emphasizes clinical trials, drug development, and new treatment strategies, bridging lab discoveries with clinical applications.

• Impact Factor: 11.5
• CiteScore: 21.8
• SJR: 4.603
• SNIP: 2.156
• H-Index: 362

Journal of Bone Oncology

The Journal of Bone Oncology focuses on cancer-induced bone diseases, bone metastases, and treatment-induced bone loss.

• Impact Factor: 3.4
• CiteScore: 7.2
• SJR: 0.92
• SNIP: 1.293
• H-Index: 33

Publish or Perish - as true now as it ever was

In the high-stakes world of pharma and biotech, "Publish or Perish" isn't just a catchy phrase—it's the stark reality. For pharma companies and researchers, it's not enough to develop breakthroughs; the real challenge lies in getting those findings recognised in top journals. In this game, it's not just about playing your cards right; it's about having a seasoned player on your team. With Rx Communications in your corner, you’ll be giving yourself the best chance to make an impact with your research. Explore our Publications Support Services here.

How to Stay Up-to-Date with Sarcoma Research Developments

For pharma professionals and researchers working in the field of sarcomas, it is vital to stay abreast of the latest research advancements. To stay on top you might:

• Consider subscribing to our newsletter and receive updates to our top journal lists as well as other relevant industry and therapeutic developments as they happen.
• Register for an account with your selected journal to get direct access to new research as it's published.
• Customise an RSS feed for your selected journals to also further streamline the process, delivering the latest papers and articles directly to your digital doorstep.
• Setting up a Google alert with sarcoma research keywords to capture relevant news and studies from across the web.
• Lastly, don't underestimate the power of social media; by following the publishers and journals in the field, you'll tap into a community of shared knowledge and discourse.

Article originally written by Erin Harrison and first published in 2022, updated by Beth Howe and the Rx Team for 2024!